Healthcare Distribution Market Future Demand & Growth Analysis with Forecast up to 2028

The global healthcare distribution market size is expected to reach USD 1,384.59 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing healthcare burden of chronic diseases among the growing geriatric population. Governments in developing countries are increasingly focusing on promoting healthcare utilization as a vital policy to enhance health outcomes and meet international obligations to make health services broadly accessible. Advancements in research have resulted in development of next-generation and innovative and high-value or specialty medicines that are utilized to treat complex or rare chronic conditions.

Advancements in specialty drugs coupled with increasing demand for traditional branded and generic drugs is expected to offer lucrative growth opportunities for various pharmaceutical distributors. These factors are driving growth of the healthcare distribution market. Moreover, utilization of specialty drugs to treat complex and chronic conditions such as auto immune disorders and cancers is expected to drive demand during the forecast period. Specialty drugs require unique logistics such as cold chain handling as most of these products are biologically derived. Rising need for advanced distribution centers to handle these logistical challenges is resulting in advancements in healthcare distribution systems in order to deliver specialty products safely and securely.

Get Sample PDF Copy Of this Report At: https://www.emergenresearch.com/request-sample/699

Qualitative Analysis:

The research report includes a separate chapter for qualitative analysis. We have followed a descriptive approach while compiling the chapter. The macro and micro economic factors define the share and growth of market. These factors have been carefully understood through secondary and primary sources. All such factors have been explained under headings namely growth driving factors, growth restraining factors, market and technology trends and so on. Depending on the contribution and the growth potential, five countries were chosen for PESTEL analysis and the same has been described in the report.

Key players in the market include McKesson Corporation, Cardinal Health, AmerisourceBergen Corporation, Owens & Minor, Morris & Dickson Co. L.L.C., CuraScript SD, FFF Enterprises, Inc., Medline Industries, Attain Med, Inc., and Dakota Drug.

We provide detailed product mapping and investigation of various market scenarios. Our expert analysts provide a thorough analysis and breakdown of the market presence of key market leaders. We strive to stay updated with the recent developments and follow the latest company news related to the industry players operating in the global healthcare distribution market. This helps us to comprehensively analyze the individual standing of the companies as well as the competitive landscape. Our vendor landscape analysis offers a complete study to help you gain the upper hand in the competition.

Emergen Research has segmented the global healthcare distribution market on the basis of type, end-use, and region:

· Type Outlook (Revenue, USD Billion; 2018–2028)

o Medical Device Distribution Services

o Biopharmaceutical Product Distribution Services

1. Vaccines

2. Monoclonal Antibodies

3. Blood and Blood Products

4. Recombinant Proteins

5. Others

o Pharmaceutical Product Distribution Services

1. Generic Drugs

2. OTC Drugs

3. Brand Name or Innovator Drugs

End-use Outlook (Revenue, USD Billion; 2018–2028)

Hospital Pharmacies
Retail Pharmacies
Others

Scope of the Report:

With all the data gathered and analyzed using SWOT analysis, there was a clearer picture of the competitive landscape of the global healthcare distribution market. Sources for the future market growth were uncovered and outlying competitive threats also surfaced. There was strategic direction eminent in the market and this shows in the key trends and developments studied. By getting market background and using current norms, policies, and trends of other leading markets for cross-references, market data was completed.

Research Methodology

· Data triangulation and market breakdown

· Research assumptions Research data including primary and secondary data

· Primary data includes breakdown of primaries and key industry insights

· Secondary data includes key data from secondary sources

Proceed To Buy: https://www.emergenresearch.com/select-license/699

Some Key Highlights From the Report

· In October 2019, McKesson Corporation and Aetion announced a strategic collaboration, which is focused on advancing the use of Real-World Evidence (RWE) in cancer research in order to provide benefit to regulators, patients, payers, and the biopharma industry. The collaboration is expected to provide best-in-class solutions in multiple tumor types, including lung, breast, and melanoma cancers. The joint solutions consist of the Aetion Evidence Platform with data from McKesson’s iKnowMed oncology Electronic Health Record (EHR) system to power regulatory-grade outcomes research.

· Pharmaceutical product distribution services segment accounted for largest revenue share in 2020. Favorable investments on research and development activities for the development of pharmaceutical products is supporting growing demand and driving growth of the pharmaceutical product distribution services segment.

· Retail pharmacies segment revenue is expected to expand at a rapid CAGR during the forecast period. Availability of health and wellness services in retail pharmacies and timely delivery of mail order pharmacies is driving rising consumer preference towards retail pharmacies.

Enquire for customization in Report @ https://www.emergenresearch.com/request-for-customization/699

Table of Content

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary